Company News

    RSS Feed

Lexaria Files New Patent Application


June 22, 2017 |

Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) announces the filing of a new provisional patent application and stock and option awards.

Lexaria has successfully filed a new provisional patent application with the US Patent and Trademark Office (“USPTO”), No. 62/519,511, with a filing date of June 14, 2017. The new patent application expands Lexaria’s  … Read More

DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM

DelMar logo

June 22, 2017 |

DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI), a biopharmaceutical company focused on the development of new cancer therapies, today announced it has received Institutional Review Board (IRB) approval to conduct its pivotal Phase 3 Study in Temozolomide-Avastin (bevacizumab) Recurrent GBM (STAR-3).

“IRB approval is an essential step in initiating patient enrollment in our  … Read More